Enhanced tumorigenicity of marker expressing cells was confirmed by orthotopic implantation of CD44+CD24+ESA+ versus CD44−CD24−ESA− cells in NOD/SCID mice, with tumor forming potential being 100 fold higher in CD44+CD24+ESA+ cells [149]. Here, CD44 is linked to neoplasm.